COMP <GO>
CPIX vs UNH // REVENUE GROWTH (YOY)
Cumberland Pharmaceuticals Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CPIX 2
— UNH 8
▲ REVENUE GROWTH (YOY) LEADER: CPIX
LAST: $4.69 (+7.82%) • MKT CAP: $65.2M
revenue-growth
17.60%
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
revenue-growth
6.46%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPIX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPIX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.00% | 88.57% | -3.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -16.40% | 11.47% | -27.87 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.42% | 6.48% | +0.94 | CPIX | /fcf-yield <GO> |
| Operating Margin | -6.30% | 4.82% | -11.12 | UNH | /operating-margins <GO> |
| Net Profit Margin | -6.40% | 3.14% | -9.54 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 17.60% | 6.46% | +11.14 | CPIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.72 | 3.12 | -2.40 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.3 | 59.2 | -23.95 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $65.2M | $368.83B | -$368.77B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPIX REV | UNH REV | CPIX GROSS % | UNH GROSS % | CPIX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.5M | $447.57B | 85.0% | 88.7% | $4.8M | $16.07B |
| FY 2024 | $37.9M | $400.28B | 82.6% | 88.3% | -$678.6K | $20.70B |
| FY 2023 | $39.6M | $371.62B | — | 89.6% | $6.1M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPIX // BETA —
UNH // BETA 0.33